Adalimumab Therapy Has a Beneficial Effect on Bone Metabolism in Patients with Crohn's Disease.
about
The Impact of Conventional and Biological Disease Modifying Antirheumatic Drugs on Bone Biology. Rheumatoid Arthritis as a Case Study.Re-evaluating osteoporosis and fracture risk in Crohn's disease patients in the era of TNF-alpha inhibitors.Supplementation with 2000 IU of Cholecalciferol Is Associated with Improvement of Trabecular Bone Mineral Density and Muscle Power in Pediatric Patients with IBD.
P2860
Adalimumab Therapy Has a Beneficial Effect on Bone Metabolism in Patients with Crohn's Disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Adalimumab Therapy Has a Benef ...... Patients with Crohn's Disease.
@en
type
label
Adalimumab Therapy Has a Benef ...... Patients with Crohn's Disease.
@en
prefLabel
Adalimumab Therapy Has a Benef ...... Patients with Crohn's Disease.
@en
P2093
P2860
P1476
Adalimumab Therapy Has a Benef ...... Patients with Crohn's Disease
@en
P2093
Bernard J Walsh
Colm A O'Morain
Jacqueline S Daly
Martin Healy
Sundaram G Veerappan
P2860
P2888
P304
P356
10.1007/S10620-015-3606-Z
P577
2015-03-03T00:00:00Z
P6179
1053118434